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Obligate intracellular bacterium Chlamydia pneumoniae is a causative agent of respiratory tract infections such as community-acquired pneumonia (1, 2) . Seroepidemiological studies show a C. pneumoniae infection rate of more than 50% in adults, implying that C. pneumoniae infection is common worldwide (3) (4) (5) . Although the symptoms of infection vary from asymptomatic to pneumonia, C. pneumoniae also causes chronic diseases such as asthma (1) (2) (3) . Moreover, because C. pneumoniae interacts with various cell types such as epithelial cells, endothelial cells, monocytes/macrophages, and smooth muscle cells, the infection is also thought to be associated with atherosclerosis (3) . Although the molecular mechanisms remain unknown, accumulating evidence indicates that C. pneumoniae modulates host cell functions during infection (3) (4) (5) . For example, C. pneumoniae induces pro-inflammatory cytokines such as Interleukin (IL)-1b, IL-8, and tumor necrosis factor (TNF) a mediated by toll-like receptor (TLR) 2 and TLR 4 with or without NOD-like receptor (NLR) pyrin domain-containing protein 3 (NLRP3) inflammasome activation (5) (6) (7) (8) (9) (10) . In addition, C. pneumoniae induces lung fibrosis, which is regulated by IL-1b signaling, in mouse models (7, 11) .
In general, oxygen concentrations at sites of C. pneumoniae infection are thought to be lower compared with atmospheric conditions (12) , because the induced inflammation results in reduced oxygen in the microenvironment (13, 14) . For example, oxygen concentrations in the peribronchial tissue of the respiratory tract are in the range of 5-14% (5) . Furthermore, proliferation of bacteria also promotes oxygen consumption in infected cells (14) , resulting in further reduction of oxygen concentrations. Because these hypoxic conditions cause inflammation and excessive tissue fibrosis (14) (15) (16) , hypoxia may represent an exacerbating factor in C. pneumoniae infection. Nevertheless, only limited studies have investigated the effects of hypoxic conditions on C. pneumoniae infection (12, 13, 17) . For example, the growth of C. pneumoniae, but not Chlamydia trachomatis, is enhanced under hypoxia (12) . Thus, C. pneumoniae is adapted to hypoxic conditions, which may have a significant impact on inflammatory responses induced by the C. pneumoniae infection.
It is known that the antibacterial effects of interferon-gamma (IFN-c) or anti-chlamydial drugs such as azithromycin and doxycycline have decreased sensitivity in C. trachomatis-infected cells under hypoxic conditions (18) (19) (20) . Reduced phosphorylation of signal transducer and activator of transcription 1 (Stat-1), the transcription factor for IFN-c, may be involved in dampening the effect of IFN-c (20) , while the reasons for reduced drug sensitivity are unknown. Therefore, hypoxia may also play a significant role in drug sensitivity in C. pneumoniae-infected cells.
In this study, we assessed pro-inflammatory responses in C. pneumoniae-infected cells under hypoxic conditions. In addition, we investigated the pro-inflammatory cytokine IL-8 production, which is involved in neutrophil recruitment during the early innate immune response, and azithromycin sensitivity under hypoxic conditions. Here, we show enhanced host cell IL-8 production and reduced azithromycin sensitivity under hypoxia compared with normoxic conditions.
MATERIALS AND METHODS

Cells
Human epithelial HEp-2 cells were purchased from the Riken Cell Bank (RCB1889, Ibaraki, Japan). The cells were cultured in Dulbecco's Modified Eagle's Medium (Sigma, St. Louis, MO, USA) containing 10% heat-inactivated fetal calf serum (FCS) and antibiotics (gentamicin sulfate, 10 lg/ml; vancomycin, 10 lg/ml; amphotericin B, 1 lg/ml) (Sigma) at 37°C in 5% CO 2 .
Bacteria and inclusion forming unit (IFU) assay
Chlamydia pneumoniae strain TW183 was kindly provided by G. Byrne, University of Wisconsin, Madison, WI, USA. The bacteria were propagated in HEp-2 cells as described previously (10) . The infected cells were collected at 3 days post-infection and then disrupted by freezing-thawing. After brief centrifugation at 180 g for 5 min to remove cell debris, the bacteria were concentrated at 9000 g for 10 min at 4°C.
The resulting bacterial pellets were suspended in sucrosephosphate-glutamic acid buffer and stored at À80°C until use. The number of infectious progenies for C. pneumoniae was determined as the inclusion forming unit (IFU) by counting the chlamydial inclusions formed in HEp-2 cells using fluorescein isothiocyanate (FITC)-conjugated monoclonal anti-Chlamydia lipopolysaccharide (LPS) antibody (with Evans Blue) (Denka Seiken, Tokyo, Japan).
Infection
HEp-2 cells (5 9 10 4 cells/well) were seeded in 24-well plates and infected with C. pneumoniae at a multiplicity of infection (MOI) of 2 for 30 min by centrifugation at 800 g at room temperature. After centrifugation, infected cells were incubated in freshly prepared RPMI 1640 (Sigma) containing 10% FCS and antibiotics for up to 72 h. The culture was performed in a Modular Incubator Chamber (MIC-101, Billups-Rothenberg, Del Mar, CA, USA) under humid normal oxygen conditions (21% O 2, 5% CO 2, 74% N 2 ) or hypoxic conditions (2% O 2, 5% CO 2, 93% N 2 ). The oxygen concentration was monitored with a personal oxygen monitor (XO-2200, New Cosmos Electric Co., Ltd., Osaka, Japan) in the culture chamber. Infected cells were collected to assess the IFU number, chlamydial 16S rDNA amounts, and inclusion formations. 
Quantitative (q) PCR
Immunofluorescent antibody staining
Infected cells on coverslips were fixed with ethanol and then stained with FITC-conjugated monoclonal anti-Chlamydia LPS antibody (with Evans Blue) (Denka Seiken). The stained cells were observed using a BioRevo BZ-9000 fluorescence microscope (Keyence, Osaka, Japan).
qPCR array
To confirm the expression of inflammation-related genes, we used the Human Inflammatory Response and Autoimmunity RT 2 Profiler PCR Array kit (Qiagen, Valencia, CA, USA) equipped with 84 genes (Table S1) 
Drug sensitivity test
After infection by centrifugation, the infected cells were incubated in 10% FCS-RPMI in the presence or absence of azithromycin (0.01-0.04 lg/ml) (LKT Laboratories, St.
Paul, MN, USA) for 72 h under normoxic or hypoxic conditions as described above.
Statistical analysis
Statistical analysis was performed using an unpaired Student's t test. A value of p < 0.05 was considered significant.
RESULTS
Enhanced growth of C. pneumoniae under hypoxic conditions Unlike C. trachomatis, C. pneumoniae can propagate under hypoxic conditions (2% O 2 ) compared with normoxia (21% O 2 ) (12, 13, 17) . We therefore confirmed that the growth of C. pneumoniae was promoted under the hypoxic condition that we imposed. As expected, both IFU values and C. pneumoniae 16S rDNA were significantly increased under our hypoxic condition compared with those under normoxic conditions at 3 days post-infection (Fig. 1A,B) . In addition, enlarged inclusions of C. pneumoniae were seen under hypoxia at 3 days post-infection (Fig. 1C) . Thus, the data clearly show that our experimental hypoxic condition could accurately reproduce the results of previous works (12, 13, 17) . We therefore used this hypoxic condition in the following experiments.
Pro-inflammatory cytokine responses under hypoxia
To investigate pro-inflammatory cytokine responses in C. pneumoniae-infected cells under our hypoxic condition, we first confirmed the mRNA expression of various inflammatory markers in the uninfected HEp-2 cells under hypoxia using a qPCR array equipped with 84 inflammation-related genes. As a result, five up-regulated genes (CCL3, CCL4, IL1A, IL23A, and PTGS2) and nine down-regulated genes (CCL17, CD14, FOS, LTB, LY96, MYD88, TIRAP, TLR4, and TLR7) were observed under the hypoxic condition (Fig. S1 ). Then, we revealed the mRNA expression of inflammatory-related genes in the infected cells. Compared with uninfected cells, 21 up-regulated genes and two down-regulated genes were identified in C. pneumoniae-infected cells under normoxic conditions ( Fig. 2A) , while 23 upregulated genes were seen under hypoxia (Fig. 2B) . No gene was down-regulated under the hypoxic condition. In both conditions, 19 genes were commonly up-regulated: CCL2, CCL3, CCL4, CCL22, CCL24, CCR7, CD40, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL8 (IL-8), IL1A, IL1B, IL6, IL23A, PTGS2, and TNF. However, C3AR1 and CCL5 were specifically up-regulated under the normoxic condition, while CCL19, CCL23, CD14, and IL10 were increased under hypoxia. Because pro-inflammatory cytokine IL-8 mRNA was strongly expressed in both conditions, we therefore assessed IL-8 levels in culture supernatants from C. pneumoniae-infected cells under normoxic or hypoxic conditions. The IL-8 production was increased in a C. pneumoniae dose-dependent manner at 1 and 2 days post-infection (Fig. 3A,B) . When the IL-8 levels were compared between normoxic and hypoxic conditions, there was a significant increase under the hypoxic condition at days 1 and 2 post-infection.
Effect of azithromycin on C. pneumoniae growth under hypoxic conditions
Next, we assessed the drug sensitivities of C. pneumoniae under our hypoxic condition. Because reduced sensitivity of azithromycin, which is a first choice drug for Chlamydia infections, has been shown in cells infected with the closely related bacterium, C. trachomatis, under hypoxic conditions (18, 19) , we performed the azithromycin sensitivity testing in C. pneumoniae-infected cells. As a result, both C. pneumoniae IFU values and 16S rDNA levels were decreased in an azithromycin dosedependent manner under both normoxic and hypoxic conditions (Fig. 4A,B) . However, both IFU values and 16S rDNA levels were significantly decreased at 0.01 lg/ml of azithromycin under normoxic conditions, while these parameters were gradually decreased between 0.01 and 0.04 lg/ml of azithromycin under hypoxia. To clarify the differences between the normoxic and hypoxic conditions, we observed inclusions of C. pneumoniae at 3 days post-infection (Fig. 4C) . No obvious inclusions were seen at 0.01 lg/ml of azithromycin under the normoxic condition, while obvious, but slightly small inclusions were seen at the same concentration of azithromycin under our hypoxic condition, and no inclusion was seen at 0.04 lg/ml of azithromycin under hypoxia. Although chlamydial propagation was promoted under the hypoxic condition, these data strongly suggest that azithromycin sensitivity was reduced under hypoxia.
DISCUSSION
Although bacterial infections result in hypoxic conditions at sites of infection (13, 14) , so far proinflammatory responses or drug sensitivity against C. pneumoniae have mainly been assessed under normoxic conditions (21% O 2 ) in vitro (6) (7) (8) (9) (10) . In the present study, we therefore assessed the effects of hypoxia on pro-inflammatory responses and azithromycin sensitivity in C. pneumoniae-infected cells. We found that the hypoxic condition resulted in significantly increased host inflammatory cytokine IL-8 production and dampened the effects of azithromycin against C. pneumoniae compared with the normoxic condition.
In general, a master regulator, hypoxia-inducible factor (HIF)-1 transcription factor, is known to be stabilized under hypoxic conditions (14, 15) . HIF-1 consists of two subunits, HIF-1a and HIF-1b. Of them, HIF-1a is hydroxylated by prolyl hydroxylase (PHD) in normal oxygen conditions. However, PHD becomes inactive under hypoxia. Subsequently, HIF-1a is stabilized and functions as a master regulator of many cell responses including inflammatory responses (14, 15) . In addition, C. pneumoniae can also stabilize HIF-1a to cause glucose uptake as well as efficient proliferation of chlamydia in the early phase of infection (13) . In fact, in contrast with the normoxic condition, enhanced growth and enlarged inclusions of C. pneumoniae were seen under hypoxia, indicating that the hypoxic condition that we imposed worked adequately, as reported previously (12, 13, 17) .
Because HIF-1 binds and transcribes mRNA expression of inflammatory-related genes, hypoxic conditions enhance inflammatory responses in various cells (14, 15) . We therefore assessed changes in gene expression in C. pneumoniae-infected cells between the normoxic and hypoxic conditions using a qPCR array equipped with 84 inflammation-related genes. We found that two and four genes were specifically up-regulated under normoxic and hypoxic conditions, respectively. Furthermore, 19 genes were commonly up-regulated, which suggests that similar gene expression may be induced by C. pneumoniae infection under both conditions. However, when we determined the amounts of IL-8, which was strongly expressed in C. pneumoniae-infected cells in both conditions, a significant increase in IL-8 production was seen under the hypoxic condition. Thus, the results suggest that hypoxia and C. pneumoniae infection may synergistically induce inflammatory responses in host cells. Conversely, it has been reported that hypoxic conditions resulted in decreased secretion of inflammatory mediators or expression of receptors of the innate immunity such as TLR (24) (25) (26) . In fact, we identified nine downregulated genes in uninfected HEp-2 cells under the hypoxic condition. Although the effects of hypoxic conditions on inflammatory responses remain controversial, our data show that pro-inflammatory cytokine production was positively regulated by the hypoxic condition in C. pneumoniae-infected cells.
When the sensitivity of a first-line drug, azithromycin, was examined in C. pneumoniae-infected cells, the hypoxic condition significantly decreased the effects of this drug against C. pneumoniae. Interestingly, the antibacterial effect of IFN-c, which plays a central role in protective immunity against Chlamydia, was also impaired by reduced phosphorylation of the transcription factor Stat-1 under hypoxic conditions (19, 20, 27) , suggesting that effects of antibacterial cytokines and antibiotics may be dampened under hypoxia. Although the exact reasons remain unknown, multidrug resistance protein 1 and multidrug resistance-associated protein 1, which are upregulated by stabilized HIF-1 under hypoxic conditions, may be involved in reducing antibacterial effects (18, 19) .
In conclusion, we show that hypoxic conditions enhance host inflammatory responses and reduce drug sensitivity in C. pneumoniae-infected cells. These results suggest the possibility that inflammatory responses and drug sensitivity in C. pneumoniae infection may have been previously underestimated. Thus, to understand Chlamydia infection accurately, it may be necessary to perform in vitro experiments under hypoxic conditions.
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